Arca
Skip to content

IFNAR1: Interferon alpha/beta receptor 1

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Together with IFNAR2, forms the heterodimeric receptor for type I interferons (including interferons alpha, beta, epsilon, omega and kappa).

  • Drugs that act on it: 1
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
DrugUS approvalMechanismActionWarnings
AnifrolumabApprovedInterferon-alpha/beta receptor alpha chain antagonistAntagonist—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Immunodeficiency 106, susceptibility to viral infections
0.70
Chronic hepatitis B virus infection
0.61
Neoplasm
0.61
Hepatitis B virus infection
0.61
Chronic hepatitis C virus infection
0.60
Hepatitis C virus infection
0.60
Acquired polycythemia vera
0.58
HIV infectious disease
0.52

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
IFNAR1

Drugs and mechanisms are from ChEMBL CHEMBL1887 (CC BY-SA 3.0). Gene name, function (UniProt P17181, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.